VAISHALI PHARMA Financial Statement Analysis
|
||
|
The Revenues of VAISHALI PHARMA have decreased by -8.12% YoY .
The Earnings Per Share (EPS) of VAISHALI PHARMA has decreased by -89.30 % YoY. |
||
| REVENUES |
| OPERATING MARGIN |
| PROFIT AFTER TAX |
| EPS |
| ROCE |
VAISHALI PHARMA Last 5 Annual Financial Results
[NSE : VAISHALI]
| Standalone | Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 |
|---|---|---|---|---|---|
| Revenues | ₹70 Cr | ₹76 Cr | ₹5,377,389 Cr | ₹60 Cr | ₹75 Cr |
| Expenses | ₹60 Cr | ₹69 Cr | ₹5,112,586 Cr | ₹59 Cr | ₹73 Cr |
| Operating Profit (Excl OI) | ₹9.38 Cr | ₹6.89 Cr | ₹264,803 Cr | ₹0.90 Cr | ₹2.08 Cr |
| Other Income | ₹2.23 Cr | ₹1.79 Cr | ₹180,910 Cr | ₹2.17 Cr | ₹1.98 Cr |
| Interest | ₹2.26 Cr | ₹2.49 Cr | ₹262,568 Cr | ₹2.56 Cr | ₹2.66 Cr |
| Depreciation | ₹0.50 Cr | ₹0.46 Cr | ₹42,693 Cr | ₹0.44 Cr | ₹0.27 Cr |
| Profit Before Tax | ₹8.85 Cr | ₹5.73 Cr | ₹140,452 Cr | ₹0.08 Cr | ₹1.13 Cr |
| Profit After Tax | ₹6.60 Cr | ₹4.02 Cr | ₹104,626 Cr | ₹0.03 Cr | ₹0.71 Cr |
| Earnings Per Share (Rs) | ₹0.67 | ₹6.26 | ₹3.82 | ₹0.99 | ₹0.03 |
| PAT Margin (%) | 0.83 | 9.48 | 5.31 | 1.95 | 0.05 |
| ROE(%) | 2.09 | 22.26 | 16.50 | 4.78 | 0.15 |
| ROCE(%) | 5.82 | 21.92 | 18.87 | 10.33 | 6.89 |
| Total Debt/Equity(x) | 0.35 | 0.41 | 0.79 | 0.78 | 0.78 |
Key Financials |
||
| Market Cap | : | ₹ 130.5 Cr |
| Revenue (TTM) | : | ₹ 104.7 Cr |
| Net Profit(TTM) | : | ₹ 0.4 Cr |
| EPS (TTM) | : | ₹ 0.0 |
| P/E (TTM) | : | 327.9 |
| Industry Peers & Returns | 1W | 1M | 1Y |
| VAISHALI PHARMA | -2% | -11% | -44.7% |
| SUN PHARMACEUTICAL INDUSTRIES | -1.4% | 3.6% | -7.8% |
| DIVIS LABORATORIES | 4.4% | 15.9% | 15.6% |
| CIPLA | -4.9% | -0.8% | 6.6% |
| TORRENT PHARMACEUTICALS | -0.6% | 1.8% | 15.7% |
| DR REDDYS LABORATORIES | -4.1% | -3.8% | -4.3% |
| MANKIND PHARMA | -3.1% | -3.3% | -8.6% |
| ZYDUS LIFESCIENCES | -2.9% | -1.6% | -0.5% |
| LUPIN | 2.1% | 1.3% | -8% |
VAISHALI PHARMA Revenues
[NSE : VAISHALI]
| Y-o-Y | -8.12 % |
| 5 Yr CAGR | -1.86 % |
| Years | Revenues | % Change | |
|---|---|---|---|
| Mar2024 | ₹70 Cr | -8.12 | |
| Mar2023 | ₹76 Cr | -100.00 | |
| Mar2022 | ₹5,377,389 Cr | 8,949,387.00 | |
| Mar2021 | ₹60 Cr | -19.98 | |
| Mar2020 | ₹75 Cr | - | |
VAISHALI PHARMA Operating Profit
[NSE : VAISHALI]
| Y-o-Y | 36.21 % |
| 5 Yr CAGR | 45.70 % |
| Years | Operating Profit | % Change | |
|---|---|---|---|
| Mar2024 | ₹9.38 Cr | 36.21 | |
| Mar2023 | ₹6.89 Cr | -100.00 | |
| Mar2022 | ₹264,803 Cr | 29,389,784.57 | |
| Mar2021 | ₹0.90 Cr | -56.70 | |
| Mar2020 | ₹2.08 Cr | - | |
| Operating Margins | |
|---|---|
| Y-o-Y | 48.24 % |
| 5 Yr CAGR | 48.47 % |
| Years | Operating Margin% | % Change | |
|---|---|---|---|
| Mar2024 | 13.46% | 48.24 | |
| Mar2023 | 9.08% | 84.55 | |
| Mar2022 | 4.92% | 228.00 | |
| Mar2021 | 1.5% | -45.85 | |
| Mar2020 | 2.77% | - | |
VAISHALI PHARMA Profit After Tax
[NSE : VAISHALI]
| Y-o-Y | 64.12 % |
| 5 Yr CAGR | 74.39 % |
| Years | Profit After Tax | % Change | |
|---|---|---|---|
| Mar2024 | ₹6.60 Cr | 64.12 | |
| Mar2023 | ₹4.02 Cr | -100.00 | |
| Mar2022 | ₹104,626 Cr | 317,047,384.85 | |
| Mar2021 | ₹0.03 Cr | -95.38 | |
| Mar2020 | ₹0.71 Cr | - | |
| PAT Margins | |
|---|---|
| Y-o-Y | -91.24 % |
| 5 Yr CAGR | 101.85 % |
| Years | PAT Margin(%) | % Change | |
|---|---|---|---|
| Mar2024 | 0.83 % | -91.24 | |
| Mar2023 | 9.48 % | 78.53 | |
| Mar2022 | 5.31 % | 172.31 | |
| Mar2021 | 1.95 % | 3,800.00 | |
| Mar2020 | 0.05 % | - | |
VAISHALI PHARMA Earnings Per Share (EPS)
[NSE : VAISHALI]
| Y-o-Y | -89.30 % |
| 5 Yr CAGR | 117.39 % |
| Years | EPS | % Change | |
|---|---|---|---|
| Mar2024 | ₹0.67 | -89.30 | |
| Mar2023 | ₹6.26 | 63.87 | |
| Mar2022 | ₹3.82 | 285.86 | |
| Mar2021 | ₹0.99 | 3,200.00 | |
| Mar2020 | ₹0.03 | - | |
VAISHALI PHARMA Return on Capital Employed (ROCE)
[NSE : VAISHALI]
| Y-o-Y | -73.45 % |
| 5 Yr CAGR | -4.13 % |
| Years | ROCE | % Change | |
|---|---|---|---|
| Mar2024 | 5.82% | -73.45 | |
| Mar2023 | 21.92% | 16.16 | |
| Mar2022 | 18.87% | 82.67 | |
| Mar2021 | 10.33% | 49.93 | |
| Mar2020 | 6.89% | - | |
VAISHALI PHARMA Share Price vs Sensex
| Current Share Price | : | ₹10.0 |
| Current MarketCap | : | ₹ 130.5 Cr |
| Updated EOD on | : | Nov 04,2025 |
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| VAISHALI PHARMA | -2% |
-11% |
-44.7% |
| SENSEX | -1.4% |
3.1% |
3.8% |
VAISHALI PHARMA related INDICES
No BSE index found!
No NSE index found
You may also like the below Video Courses
FAQ about VAISHALI PHARMA Financials
How the annual revenues of VAISHALI PHARMA have changed ?
The Revenues of VAISHALI PHARMA have decreased by -8.12% YoY .
How the Earnings per Share (EPS) of VAISHALI PHARMA have changed?
The Earnings Per Share (EPS) of VAISHALI PHARMA has decreased by -89.30 % YoY .
Check out Intrinsic Value of Peers of VAISHALI PHARMA
Compare Stock Analytics of Peers of VAISHALI PHARMA
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs
